Skip to main content
. 2022 Oct 1;48(10):438–448.

Table 3. Results from the final selected models at the provincial level for study objective 2a,b.

Province Model variables BIC M-Li nV H C nObs
β CI low CI high p-value β CI low CI high p-value
BC H_lag14 260.3 1 0 6.44E-02 1.41E-02 1.15E-01 1.21E-02 N/A N/A N/A N/A 51
H_lag7 261.9 1 0 5.41E-02 1.87E-03 1.06E-01 4.23E-02 N/A N/A N/A N/A 51
H 265.2 1 0 2.34E-02 -2.73E-02 7.40E-02 3.66E-01 N/A N/A N/A N/A 51
AB H_lag7 + C 233.8 1 0 2.70E-02 1.50E-02 3.90E-02 1.02E-05 -4.48 -8.97 1.17E-02 5.06E-02 50
H 231.1 1 0 2.60E-02 1.42E-02 3.78E-02 1.58E-05 N/A N/A N/A N/A 50
H_lag14 242.5 1 0 1.45E-02 1.26E-03 2.77E-02 3.18E-02 N/A N/A N/A N/A 50
SK H_lag7 + C 278.7 1 0 2.35E-02 -7.84E-02 1.25E-01 6.51E-01 2.12 -3.93 8.18 4.91E-01 50
H + C 278.8 1 0 1.88E-02 -7.87E-02 1.16E-01 7.05E-01 2.68 -3.26 8.63 3.76E-01 50
H_lag14 + C 278.9 1 0 1.63E-03 -1.01E-01 1.04E-01 9.75E-01 2.47E -3.49 8.43 4.16E-01 50
MB H_lag7 233.4 1 0 2.88E-02 2.70E-04 5.73E-02 4.79E-02 N/A N/A N/A N/A 51
H_lag14 236.1 1 0 1.49E-02 -1.45E-02 4.42E-02 3.20E-01 N/A N/A N/A N/A 51
H + C 254 1 0 7.63E-03 -2.26E-02 3.79E-02 6.21E-01 -2.04 -5.96 1.88 3.08E-01 51
ON H_lag14 266 1 0 1.55E-02 7.74E-03 2.32E-02 8.77E-05 N/A N/A N/A N/A 51
H_lag7 269.1 1 0 1.40E-02 5.78E-03 2.23E-02 8.52E-04 N/A N/A N/A N/A 51
H 273.8 1 0 1.02E-02 -4.22E-04 2.08E-02 5.98E-02 N/A N/A N/A N/A 51
QC H + C 243.5 1 0 8.36E-03 1.29E-03 1.54E-02 2.05E-02 -2.48 -5.29 3.36E-01 8.44E-02 51
H_lag7 229.9 1 0 6.90E-03 4.02E-04 1.34E-02 3.74E-02 N/A N/A N/A N/A 51
H_lag14 + C 247.5 1 0 3.13E-03 -3.51E-03 9.77E-03 3.55E-01 -2.34 -4.84 1.68E-01 6.75E-02 51

Abbreviations: AB, Alberta; β, beta coefficient of the variable; BC, British Columbia; BIC, Bayesian Information Criterion; C, period of time with combined effects of vaccination, Alpha variant and winter; CI, 95% confidence interval; H, number of hospitalized COVID-19 patients; lag7, time lags at seven days; lag14, time lags at 14 days; MB, Manitoba; M-Li, McLeod-Li test; N/A, not applicable; nObs, number of observations for model fitting; nV, number of violations in the McLeod-Li test; ON, Ontario; QC, Québec; sidx, stringency index; SK, Saskatchewan

a Results from the final selected models at the provincial level for study objective 2 of general model formulation: sidx ~ H and assessing for confounding from vaccination, the Alpha variant and winter

b Models highlighted in grey were significant at p-value ≤0.05 and pass the McLeod-Li test with two or fewer violations (nV). The models are ordered by the absolute value of the beta coefficient for the number of hospitalized COVID-19 patients. Also shown are the 95% confidence intervals for beta